
ImageneBio, Inc. — Investor Relations & Filings
ImageneBio, Inc. is a clinical-stage biotechnology company that develops therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company's lead candidate is IMG-007, a next-generation investigational anti-OX40 monoclonal antibody. IMG-007 is designed with an extended half-life to target and inhibit OX40 receptor signaling without depleting T cells, aiming to provide a potential best-in-class treatment with enhanced efficacy, safety, and patient convenience.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 - ImageneBio, Inc. (0001835579) (Filer) | 2026-05-07 | English | |
| ARS - ImageneBio, Inc. (0001835579) (Filer) | 2026-04-30 | English | |
| 424B3 - ImageneBio, Inc. (0001835579) (Filer) | 2026-04-13 | English | |
| 8-K - ImageneBio, Inc. (0001835579) (Filer) | 2026-04-13 | English | |
| 4 - ImageneBio, Inc. (0001835579) (Issuer) | 2026-03-18 | English | |
| 8-K - ImageneBio, Inc. (0001835579) (Filer) | 2026-03-17 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 43589343 | 424B3 - ImageneBio, Inc. (0001835579) (Filer) | 2026-05-07 | English | ||
| 39218276 | ARS - ImageneBio, Inc. (0001835579) (Filer) | 2026-04-30 | English | ||
| 34412167 | 424B3 - ImageneBio, Inc. (0001835579) (Filer) | 2026-04-13 | English | ||
| 34406644 | 8-K - ImageneBio, Inc. (0001835579) (Filer) | 2026-04-13 | English | ||
| 32980329 | 4 - ImageneBio, Inc. (0001835579) (Issuer) | 2026-03-18 | English | ||
| 32967518 | 8-K - ImageneBio, Inc. (0001835579) (Filer) | 2026-03-17 | English | ||
| 31990125 | 424B3 Filing | 2026-02-17 | English | ||
| 31990011 | 8-K Filing | 2026-02-17 | English | ||
| 31990023 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31990018 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
| 13348842 | Major Shareholding Notification 2026 | 2026-01-06 | English | ||
| 13348843 | Director's Dealing 2026 | 2026-01-03 | English | ||
|
2025
3 filings
| |||||
| 13348844 | Director's Dealing 2025 | 2025-12-29 | English | ||
| 13348845 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 13348846 | Director's Dealing 2025 | 2025-12-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
|
Bioceltix S.A.
Develops stem cell-based medicinal products for veterinary …
|
BCX | PL | Manufacturing |
|
BioChem Pharma Inc.
Produces and commercializes high-quality pharmaceuticals, f…
|
— | CA | Manufacturing |
ImageneBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34275/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34275 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34275 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34275 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34275}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ImageneBio, Inc. (id: 34275)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.